I tend to take a libertarian view of healthcarepeople should have broad autonomy over decisions about their own bodies, as long as they are fully informed
Swissmedic has noticed several concerning trends as regards unauthorised or in some cases falsified products that make reference to GLP-1
doi: 10.1016/j.cmet.2019.09.016 Summary Keywords type 2 diabetes mellitus, cardiovascular disease, acylcarnitine, metabolism, relationship Citation Zhao S, Liu M-L, Huang B, Zhao F-R, Li Y, Cui X-T and Lin R (2021) Acetylcarnitine Is Associated With Cardiovascular Disease Risk in Type 2 Diabetes Mellitus
Weight Loss: The average percent weight loss from patients starting weight after these 18 months at each maintenance dose was: - 15% weight loss from baseline body weight at the 5mg dose -19.5% weight loss from baseline body weight at the 10mg dose -20.9% weight loss from baseline body weight at the 15mg dose (maximum dose) By contrast, the control group saw an average 3.1% weight loss compared to their baseline weight at 72 weeks